Model for End-Stage Liver Disease score for cirrhosis severity and transplant priority
Primary source: Kamath PS et al. Hepatology 2001; 33(2): 464-470 (MELD). UNOS модификации округления
MELD (Model for End-Stage Liver Disease; Kamath PS et al., Hepatology 2001) is a formula-based score for predicting 3-month mortality in patients with severe liver disease. It uses 3 objective parameters: total bilirubin, INR, and creatinine (since 2016, sodium has also been incorporated as MELD-Na).
Formula: MELD = 3.78×ln(bilirubin, mg/dL) + 11.2×ln(INR) + 9.57×ln(creatinine, mg/dL) + 6.43. The result is rounded to the nearest integer. Minimum 6, maximum 40 (capped in practice).
MELD is used primarily to prioritize patients on the liver transplant waiting list: the higher the MELD score, the higher the priority. It is also used to predict outcomes after TIPS, to assess perioperative risk in patients with cirrhosis undergoing surgery, and in acute liver injury. Since 2016, MELD-Na has been the standard for liver transplant allocation under UNOS/OPTN policy in the United States. Its advantage over Child-Pugh is full objectivity and inclusion of renal function.
58-year-old woman with HCV cirrhosis. Bilirubin 102 µmol/L (6.0 mg/dL), INR 2.1, creatinine 130 µmol/L (1.5 mg/dL), sodium 132 mmol/L.
MELD-Na ≈ 3.78×ln(6.0) + 11.2×ln(2.1) + 9.57×ln(1.5) + 6.43 + sodium correction ≈ 24.
MELD-Na 24 indicates a high risk of 3-month mortality (~20%). Management: urgent referral to a transplant center, optimization of therapy (ascites control, SBP prophylaxis, lactulose), and HCC screening. At MELD ≥15, transplantation reduces mortality compared with medical management alone (the MELD-15 cutoff rule).
Validated scores and formulas with full interpretation, clinical examples and source references. Open access, no registration required.
65+ calculators · scores and formulas · interpretation with management notes